| Date Filed | Type | Description |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 66,385 rights
@ $0 |
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $3.76, valued at
$7.6k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2022 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $6.07, valued at
$12.2k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 01/14/2022 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 2,012 shares
@ $8.3, valued at
$16.7k
Exercised 1,250 restricted stock units
@ $0
Exercised 4,564 restricted stock units
@ $0 |
|
| 12/23/2021 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 817 shares
@ $9.3585, valued at
$7.6k
|
|
| 10/15/2021 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 433 shares
@ $10.55, valued at
$4.6k
Exercised 1,250 restricted stock units
@ $0
Granted 92,200 options to buy
@ $10.55, valued at
$972.7k
Granted 55,320 restricted stock units
@ $0 |
|
| 07/15/2021 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 971 shares
@ $13.8975, valued at
$13.5k
Paid exercise price by delivering 433 shares
@ $13.48, valued at
$5.8k
Exercised 1,250 restricted stock units
@ $0 |
|
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 637 shares
@ $11.6535, valued at
$7.4k
|
|
| 10/15/2020 |
4
| POYHONEN JOHN (President & CCO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 170,000 options to buy
@ $15.72, valued at
$2.7M
Granted 20,000 restricted stock units
@ $0 |
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2019 |
4
| POYHONEN JOHN (EVP, Chief Commercial Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 300,000 options to buy
@ $18.29, valued at
$5.5M
|
|
| 05/23/2019 |
4
| POYHONEN JOHN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Bought 3,000 shares
@ $17.55, valued at
$52.7k
|
|
| 12/18/2018 |
4
| POYHONEN JOHN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 19,500 options to buy
@ $24.97, valued at
$486.9k
Granted 30,000 options to buy
@ $24.97, valued at
$749.1k
|
|
| 11/02/2018 |
4
| POYHONEN JOHN (President & CEO) has filed a Form 4 on SENOMYX INC|
Txns:
| Unknown transaction of 111,469 shares
@ $1.5, valued at
$167.2k
Unknown transaction of 108,293 shares
@ $1.5, valued at
$162.4k
Disposed/sold 417,000 options to buy
@ $1.02, valued at
$425.3k
Disposed/sold 363,000 options to buy
@ $1.05, valued at
$381.2k
|
|
| 03/21/2018 |
4
| POYHONEN JOHN (President & CEO) has filed a Form 4 on SENOMYX INC|
Txns:
| Granted 15,545 shares
@ $0
Granted 363,000 options to buy
@ $1.05, valued at
$381.2k
|
|
| 12/20/2017 |
4
| POYHONEN JOHN (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 19,500 options to buy
@ $17, valued at
$331.5k
|
|
| 03/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| POYHONEN JOHN (President & CEO) has filed a Form 4 on SENOMYX INC|
Txns:
| Granted 2,191 shares
@ $2.8988, valued at
$6.4k
|
|
| 04/17/2013 |
4
| POYHONEN JOHN (See Remarks) has filed a Form 4 on SENOMYX INC|
Txns:
| Granted 4,438 shares
@ $0
Granted 205,000 options to buy
@ $2.11, valued at
$432.6k
|
|
| 06/20/2012 |
4
| POYHONEN JOHN (Director) has filed a Form 4 on Ardea Biosciences, Inc./DE|
Txns:
| Disposed/sold 12,500 options to buy
@ $5.85, valued at
$73.1k
Disposed/sold 12,500 options to buy
@ $15.69, valued at
$196.1k
Disposed/sold 10,000 options to buy
@ $15.69, valued at
$156.9k
Disposed/sold 12,500 options to buy
@ $12.16, valued at
$152k
Disposed/sold 5,000 options to buy
@ $12.16, valued at
$60.8k
Disposed/sold 12,500 options to buy
@ $14.29, valued at
$178.6k
Disposed/sold 12,500 options to buy
@ $25.97, valued at
$324.6k
Disposed/sold 12,500 options to buy
@ $16.47, valued at
$205.9k
|
|
| 03/01/2012 |
4
| POYHONEN JOHN (See Remarks) has filed a Form 4 on SENOMYX INC|
Txns:
| Granted 1,880 shares
@ $0 |
|
| 02/16/2012 |
4
| POYHONEN JOHN (See Remarks) has filed a Form 4 on SENOMYX INC|
Txns:
| Granted 225,000 options to buy
@ $3.3, valued at
$742.5k
|
|
| 01/05/2012 |
4
| POYHONEN JOHN (Director) has filed a Form 4 on Ardea Biosciences, Inc./DE|
Txns:
| Granted 12,500 options to buy
@ $16.47, valued at
$205.9k
|
|
|